Clinical Trial Outcomes — Anonymized (2024)
Anonymized clinical trial outcome data covering 340 Phase II and Phase III trials completed in 2024. Includes efficacy endpoints, adverse event frequencies, demographic breakdowns, and protocol metadata. HIPAA-safe with k-anonymity (k=5) guarantees. Useful for pharmaceutical research, biostatistics, and health economics.
Licence summary — not the contract
- Not the contract — read and download the full licence before accepting.
- You may use this delivered dataset version inside your business, including through affiliates and contractors working for you.
- You own and may commercialise your models, outputs and derived work if the raw dataset cannot be extracted or reconstructed.
- You may not redistribute or resell the dataset itself, or try to identify or re-identify people.
- AI/ML training is permitted for this listing.
- You have seven days to report a material mismatch; the remedy is fix or refund, and a refund ends the licence and requires deletion within 30 days.
- ai.market is not a party and gives no legal advice; New York law governs.
AI/ML training is permitted for this listing.
ai.market Standard Data Licence v1.0
https://ai.market/licenses/standard/1.0/ai-trainingSHA-256: 4b05dbcd0c186746d3deab6c68beaebba88610de8e85122efb4d527edb1263c6
ai.market Marketplace Listing Covenant v1.0
/licenses/marketplace-listing/1.0SHA-256: a91234b67bf7467a0c80f6e1caa47b563032e94751146901b796eaaf220431af
Not yet available to buy. The seller needs to accept the current terms.
Schema Information
| Column | Type |
|---|---|
| trial_id | string |
| phase | string |
| therapeutic_area | string |
| primary_endpoint | string |
| efficacy_result | float |
| adverse_events | json |
| demographics | json |
| protocol_id | string |
$2,500.00
Trust Metrics
Publisher
ai.market Seller
Ask a Question
allAI checks current public information to answer questions about this listing.
Non-Custodial
Data never touches ai.market. Transactions are peer-to-peer.